Question 1

How many shares of GYRE does BlackRock, Inc. own?

Accepted Answer

As of 2026-Q2, BlackRock, Inc. holds 993,943 shares of GYRE (GYRE THERAPEUTICS INC).

Question 2

What is BlackRock, Inc.'s GYRE position worth?

Accepted Answer

As of 2026-Q2, BlackRock, Inc.'s GYRE position is worth $6.6M.

Question 3

Is BlackRock, Inc. buying or selling GYRE?

Accepted Answer

In 2026-Q2, BlackRock, Inc. increased their GYRE position (+31.0% change in shares).

Question 4

When did BlackRock, Inc. first buy GYRE?

Accepted Answer

Based on available 13F filings, BlackRock, Inc. first reported a position in GYRE in 2024-Q4. They have held the position across 7 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	993,943	+31.0%	$6.6M	0.0%	$6.59	35
2026-Q1	Increased	758,630	+5.3%	$5.3M	0.0%	$7.90	28
2025-Q4	Increased	720,291	+9.2%	$5.1M	0.0%	$7.02	29
2025-Q3	Decreased	659,397	-21.7%	$4.9M	0.0%	$7.50	0
2025-Q2	Increased	842,609	+54.0%	$6.2M	0.0%	$7.42	38
2025-Q1	Increased	547,210	+2.9%	$4.2M	0.0%	$9.11	28
2024-Q4	New	531,680	-	$6.4M	0.0%	$12.66	38

GYRE7 quarters

GYRE
7 quarters